| 中文名 | 2,4-二氯-5-乙基嘧啶 |
|---|---|
| 英文名 | 2,4-Dichloro-5-ethylpyrimidine |
| 英文别名 |
2,4-Dichloro-5-ethylpyrimidine
Pyrimidine, 2,4-dichloro-5-ethyl- 2,4-dichloro-5-ethyl-pyrimidine |
| 密度 | 1.3±0.1 g/cm3 |
|---|---|
| 沸点 | 245.5±20.0 °C at 760 mmHg |
| 分子式 | C6H6Cl2N2 |
| 分子量 | 177.031 |
| 闪点 | 126.0±7.4 °C |
| 精确质量 | 175.990799 |
| PSA | 25.78000 |
| LogP | 2.15 |
| 蒸汽压 | 0.0±0.5 mmHg at 25°C |
| 折射率 | 1.543 |
| 储存条件 | 2-8°C， 惰性气体 |
|
~99%
34171-40-9 |
| 文献：Taisho Pharmaceutical Co. Ltd.; Arena Pharmaceuticals, Inc. Patent: EP1464335 A2, 2004 ; Location in patent: Page/Page column 329 ; EP 1464335 A2 |
|
~%
34171-40-9 |
| 文献：McIver, Edward G.; Bryans, Justin; Birchall, Kristian; Chugh, Jasveen; Drake, Thomas; Lewis, Stephen J.; Osborne, Joanne; Smiljanic-Hurley, Ela; Tsang, William; Kamal, Ahmad; Levy, Alison; Newman, Michelle; Taylor, Debra; Arthur, J. Simon C.; Clark, Kristopher; Cohen, Philip Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 23 p. 7169 - 7173,5 |
|
~%
34171-40-9 |
| 文献：McIver, Edward G.; Bryans, Justin; Birchall, Kristian; Chugh, Jasveen; Drake, Thomas; Lewis, Stephen J.; Osborne, Joanne; Smiljanic-Hurley, Ela; Tsang, William; Kamal, Ahmad; Levy, Alison; Newman, Michelle; Taylor, Debra; Arthur, J. Simon C.; Clark, Kristopher; Cohen, Philip Bioorganic and Medicinal Chemistry Letters, 2012 , vol. 22, # 23 p. 7169 - 7173,5 |
| 上游产品 3 | |
|---|---|
| 下游产品 2 | |
| 海关编码 | 2933599090 |
|---|---|
| 中文概述 | 2933599090. 其他结构上有嘧啶环的化合物(包括其他结构上有哌嗪环的化合物. 增值税率:17.0%. 退税率:13.0%. 监管条件:无. 最惠国关税:6.5%. 普通关税:20.0% |
| 申报要素 | 品名, 成分含量, 用途, 乌洛托品请注明外观, 6－己内酰胺请注明外观, 签约日期 |
| Summary | 2933599090. other compounds containing a pyrimidine ring (whether or not hydrogenated) or piperazine ring in the structure. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:20.0% |
